David T Arnold

David T Arnold i

University of Bristol - Bristol / United Kingdom
Medical and Health Sciences / Chest Diseases
AD Scientific Index ID: 4323278
person_outline David T Arnold's MOST POPULAR ARTICLES
1-) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trialO Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ...The Lancet 397 (10285), 1637-1645, 2021815*2021
2-) Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohortDT Arnold, FW Hamilton, A Milne, AJ Morley, J Viner, M Attwood, A Noel, ...Thorax 76 (4), 399-401, 20214032021
3-) RECOVERY Collaborative Group Dexamethasone in hospitalized patients with Covid-19P Horby, WS Lim, JR Emberson, M Mafham, JL Bell, L Linsell, N Staplin, ...N Engl J Med 384 (8), 693-704, 2021635*2021
4-) Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort studyRA Evans, H McAuley, EM Harrison, A Shikotra, A Singapuri, M Sereno, ...The Lancet Respiratory Medicine 9 (11), 1275-1287, 20215932021
5-) Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trialO Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ...The Lancet 399 (10325), 665-676, 2022489*2022